A Novel Imidazopyridine Derivative Exhibits Anticancer Activity in Breast Cancer by Inhibiting Wnt/β‑catenin Signaling

BACKGROUND: Breast cancer exhibits poor prognosis and high relapse rates following chemotherapy therapeutics. Thus, this study aims to develop effective novel agents regulating the core molecular pathway of breast cancer such as Wnt/β-catenin signaling. METHODS: The present study screened a novel in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Onco Targets Ther
Autori principali: He, Liu-Jun, Yang, Dong-Lin, Chen, He-Ying, Huang, Jiu-Hong, Zhang, Ya-Jun, Qin, Hong-Xia, Wang, Juan-Li, Tang, Dian-Yong, Chen, Zhong-Zhu
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2020
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7553630/
https://ncbi.nlm.nih.gov/pubmed/33116593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S266752
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi